Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2016, Vol. 43 Issue (5): 650-653    DOI: 10.12891/ceog2137.2016
Original Research Previous articles | Next articles
The predictor markers of ovarian response in poor responders under 40 years of age
B. Vural1, Y. Çakıroğlu1, F. Vural2, *()
1Kocaeli University Faculty of Medicine, Department of Obstetrics and Gynecology, Kocaeli
2Haydarpaşa Numune Teaching Hospital, Obstetrics and Gynecology Clinic, Istanbul (Turkey)
Download:  PDF(104KB)  ( 9 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Objective: To explore the ovarian reserve markers in predicting ovarian response and pregnancy rates in poor responder patients undergoing in vitro fertilization (IVF). Material and Methods: A total of 140 women < 40 years with poor ovarian response (POR), who underwent IVF were included in the study. The clinical findings compared with normal responder controls (n= 250). Regression analysis was used to search the correlation between the number of the total oocyte count retrieved and independent variables as age, FSH, LH, AMH, AFC, and E2 on the hCG day. Results: AUC ROC curve were AMH 0.804, AFC 0.701, E2 on hCG day 0.786, FSH 0.705, LH 0.527, and E2 0.479, age 0.707, respectively. E2 levels on hCG day and AMH levels were independent markers of POR. None of the factors were predictor of pregnancy rate. Conclusion: The serum E2 levels on the hCG day and AMH levels predict ovarian response, but not pregnancy rates.
Key words:  In vitro fertilization      Anti-Müllerian hormone      Poor ovarian response      Cycle cancellation      Ovarian reserve      Pregnancy rate     
Published:  10 October 2016     
*Corresponding Author(s):  F. VURAL     E-mail:  fisunvural@yahoo.com.tr

Cite this article: 

B. Vural, Y. Çakıroğlu, F. Vural. The predictor markers of ovarian response in poor responders under 40 years of age. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(5): 650-653.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog2137.2016     OR     https://ceog.imrpress.com/EN/Y2016/V43/I5/650

[1] Gyung-Mee Kim, Jung Ahn Lee, Sung Woo Park, Jung Goo Lee, Gyun-Ho Jeon. Are plasma Brain-Derived Neurotrophic Factor or reproductive hormones related to depression in PCOS patients?: a prospective cohort study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1146-1153.
[2] Yu Deng, Zhan-Hui Ou, Min-Na Yin, Pei-Ling Liang, Zhi-Heng Chen, Abraham Morse, Ling Sun. Age and anti-Műllerian hormone: prediction of cumulative pregnancy outcome in in vitro fertilization with diminished ovarian reserve[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 835-841.
[3] Aybike Pekin, Ayşe Gül Kebapçılar, Ersin Çintesun, Setenay Arzu Yılmaz, Özlem Seçilmiş Kerimoğlu. Comparison of an estradiol patch and GnRH-antagonist protocol with a letrozole/antagonist protocol for patients without oocyte development, fertilization and/or embryo development in previous IVF cycles[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 924-928.
[4] Engin Turkgeldi, Sule Yildiz, Berk Angun, Bulent Urman, Baris Ata. Oocyte yield of GnRH antagonist cycles scheduled with a short course of estradiol in the early follicular phase[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 278-282.
[5] Mahvash Zargar, Razieh Pazhouhanfar, Mahin Najafian, Parastoo Moradi Choghakabodi. Effects of intrauterine autologous platelet-rich plasma infusions on outcomes in women with repetitive in vitro fertilization failures: a prospective randomized study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 179-184.
[6] J.H. Check, E. Chang, R. Cohen. A case report supporting the concept that a role for the anti-Müllerian hormone (AMH) in normal folliculogenesis is to diminish the biological activity of follicle stimulating hormone (FSH)[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 620-621.
[7] H. Saleh, F. Moiety, A.F. Agameya, Y. Elkassar, R.M. El Sharakwy, D. Zeidan, H. Elmeligy. Comparison between antral follicle count and anti-Müllerian hormonal level in the prediction of ovarian response and pregnancy outcome in intracytoplasmic sperm injection patients: implications in personalizing ovarian stimulation[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 166-173.
[8] T. Hasegawa, K. Nakagawa, R. Sugiyama, N. Kuji, H. Nishi. Separate transfer of two frozen-thawed embryos reduces multiple gestations in assisted reproductive technology[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 215-219.
[9] S. J. Knight, A. D. Smith, H. Kim, A. C. Collier. Human placental suppressors of cytokine signalling (SOCS) and inflammatory cytokines are dysregulated in assisted reproduction, advanced maternal age and pre-term birth[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 277-286.
[10] Hue HJ, Kim SK, Choi JY, Suh DH, Kim KD, No JH, Lee JR, Jee BC, Kim YB, Jeon HW. Previous ovarian surgery increases the risk of tubal factor infertility[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 84-88.
[11] M. Minase, T. Miyamoto, N. Hayashi, G. Minase, K. Nishiwaki, K. Sengoku. A patient with a didelphys vaginal septum and infertility diagnosed by laparoscopy and magnetic resonance imaging[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 988-989.
[12] I. Korkontzelos, A. Vlachioti, P. Mavridou, A. Rapi, G. Tsanadis, T. Stefos. Heterotopic triplet pregnancy after in vitro fertilization and intracytoplasmatic sperm injection complicated with ovarian hyperstimulation syndrome single twin fetal demise and cervical incompetence: a successful obstetrical outcome[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 1007-1010.
[13] Shun Akaeda, Daiki Kobayashi, Kyoko Shioda, Mikio Momoeda. Relationship between serum progesterone concentrations and pregnancy rates in hormone replacement treatment-frozen embryo transfer using progesterone vaginal tablets[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 695-698.
[14] E.G. Aydeniz, U. Sari, T.U.K. Dilek. Pregnancy success rate at recurrent implantation failure patients after hysteroscopic endometrial injury: preliminary study[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 709-712.
[15] N. Eamudomkarn, L. Salang, K. Seejorn, P. Kleebkaow. Comparison of impact on ovarian reserve between laparoscopic and laparotomy ovarian cystectomy[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 779-783.
No Suggested Reading articles found!